Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis

European Heart Journal

Volumn 35, Issue 18, 2014, Pages 1195-1204

  Mirabel, Mariana ^a,b   Sonneville, Romain ^c   Hajage, David ^d   Novy, Emmanuel ^c   Tubach, Florence ^c   Vignon, Philippe ^e   Perez, Pierre ^f   Lavoué, Sylvain ^g   Kouatchet, Achille ^h   Pajot, Olivier ⁱ   Mekontso Dessap, Armand ^j   Tonnelier, Jean Marie ^k   Bollaert, Pierre Edouard ^l   Frat, Jean Pierre ^m   Navellou, Jean Christophe ⁿ   Hyvernat, Herve ^o   Hssain, Ali Ait ^p   Timsit, Jean François ^q   Megarbane, Bruno ^r   Wolff, Michel ^c   Trouillet, Jean Louis ^a   more..

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL LOUIS MOURIER   (France)

^e UNIVERSITY OF LIMOGES   (France)

^f CHU NANCY BRABOIS   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h ANGERS UNIVERSITY HOSPITAL   (France)

ⁱ Service de Réanimation Polyvalente CH Victor Dupouy   (France)

^j HENRI MONDOR HOSPITAL   (France)

^k SERVICE DE RHUMATOLOGIE   (France)

^l UNIVERSITY HOSPITAL OF NANCY   (France)

^m POITIERS UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^o UNIVERSITY HOSPITAL OF NICE   (France)

^p SERVICE DE RHUMATOLOGIE   (France)

^q GRENOBLE UNIVERSITY HOSPITAL   (France)

^r HÔPITAL LARIBOISIÈRE   (France)

more..

Author keywords

Heart valve disease; Intensive care; Valve surgery

Indexed keywords

VASOACTIVE AGENT;

ADULT; AGE; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL ENDOCARDITIS; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR PARAMETERS; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CRITICALLY ILL PATIENT; FEMALE; FOLLOW UP; HEART FAILURE; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE; MITRAL VALVE REPAIR; MITRAL VALVE REPLACEMENT; MULTICENTER STUDY (TOPIC); MULTIPLE ORGAN FAILURE; NEUROLOGICAL COMPLICATION; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SURGICAL MORTALITY; TIME TO TREATMENT; VEGETATION SIZE; ADOLESCENT; AGED; CLINICAL TRIAL; CRITICAL ILLNESS; CROSS-SECTIONAL STUDY; EMERGENCY TREATMENT; ENDOCARDITIS; EPIDEMIOLOGY; FRANCE; HEART VALVE DISEASES; HEART VALVE REPLACEMENT; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CRITICAL ILLNESS; CROSS-SECTIONAL STUDIES; EMERGENCY TREATMENT; ENDOCARDITIS; FEMALE; FRANCE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900324938     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht303     Document Type: Article

References (39)

1. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG Jr. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-94.
2. Thuny F, Di Salvo G, Belliard O, Avierinos JF, Pergola V, Rosenberg V, Casalta JP, Gouvernet J, Derumeaux G, Iarussi D, Ambrosi P, Calabro R, Riberi A, Collart F, Metras D, Lepidi H, Raoult D, Harle JR, Weiller PJ, Cohen A, Habib G. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: apro-spective multicenter study. Circulation 2005;112:69-75.
3. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falco V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-473.
4. Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. CID 2012;54:1230-1239.
5. Mourvillier B, Trouillet JL, Timsit JF, Baudot J, Chastre J, Regnier B, Gibert C, Wolff M. Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Int Care Med 2004;30:2046-2052.
6. Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P, Lavoue S, Kouatchet A, Pajot O, Dessap AM, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Tabah A, Trouillet JL, Wolff M. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med 2011;39:1474-1481.
7. Wolff M, Witchitz S, Chastang C, Regnier B, Vachon F. Prosthetic valve endocarditis in the ICU. Prognostic factors of overall survival in a series of 122 cases and consequences for treatment decision. Chest 1995;108:688-694.
8. Karth G, Koreny M, Binder T, Knapp S, Zauner C, Valentin A, Honninger R, Heinz G, Siostrzonek P. Complicated infective endocarditis necessitating ICU admission: clinical course and prognosis. Crit Care 2002;6:149-154.
9. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: a propensity analysis. JAMA 2003;290:3207-3214.
10. Lalani T, Cabell CH, Benjamin DK, Lasca O, Naber C, Fowler VG Jr, Corey GR, Chu VH, Fenely M, Pachirat O, Tan RS, Watkin R, Ionac A, Moreno A, Mestres CA, Casabe J, Chipigina N, Eisen DP, Spelman D, Delahaye F, Peterson G, Olaison L, Wang A. Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for treatment-selection bias. Circulation 2010;121:1005-1013.
11. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG Jr, Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH. Early surgery in patients with infective endocarditis: a propensity score analysis. CID 2007;44:364-372.
12. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F. The impact of valve surgery on short-and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 2011;32:2003-2015.
13. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW. Early surgery versus conventional treatment for infective endocarditis. NEJM 2012;366:2466-2473.
14. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Muller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and TreatmentofInfective Endocarditis ofthe European SocietyofCardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-2413.
15. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Bolger AF, Levison ME, Ferrieri P, Gerber MA, Tani LY, Gewitz MH, Tong DC, Steckelberg JM, Baltimore RS, Shulman ST, Burns JC, Falace DA, Newburger JW, Pallasch TJ, Takahashi M, Taubert KA. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111: e394-e434.
16. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. CID 2000;30:633-638.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
18. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270: 2957-2963.
19. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Int Care Med 1996;22:707-710.
20. Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-84.
21. Gaca JG, Sheng S, Daneshmand MA, O'Brien S, Rankin JS, Brennan JM, Hughes GC, Glower DD, Gammie JS, Smith PK. Outcomes for endocarditis surgery in North America: a simplified risk scoring system. J Thor Cardiovasc Surg 2011;141:98-106 e1-e2.
22. Manne MB, Shrestha NK, Lytle BW, Nowicki ER, Blackstone E, Gordon SM, Pettersson G, Fraser TG. Outcomes after surgical treatment ofnative and prosthetic valve infective endocarditis. Ann Thor Surg 2012;93:489-493.
23. Wang A, Athan E, Pappas PA, FowlerVG Jr, Olaison L, Pare C, Almirante B, Munoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabe J, Morris A, Corey GR, Cabell CH. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA 2007;297:1354-1361.
24. Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F, Riberi A, Habib G, Raoult D. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009;169:1290-1298.
25. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. JACC 1989;14:631-638.
26. Di Salvo G, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP, Vailloud JM, Derumeaux G, Gouvernet J, Ambrosi P, Lambert M, Ferracci A, Raoult D, Luccioni R. Echocardiography predicts embolic events in infective endocarditis. JACC 2001;37:1069-1076.
27. Vilacosta I, Graupner C, San Roman JA, Sarria C, Ronderos R, Fernandez C, Mancini L, Sanz O, Sanmartin JV, Stoermann W. Risk of embolization after institution of antibiotic therapy for infective endocarditis. JACC 2002;39:1489-1495.
28. Kim DH, Kang DH, Lee MZ, Yun SC, Kim YJ, Song JM, Song JK, Lee JW, Sohn DW. Impact of early surgery on embolic events in patients with infective endocarditis. Circulation 2010;122(11 Suppl.):S17-S22.
29. Sy RW, Kritharides L. Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients inAustralia. Eur Heart J 2010;31:1890-1897.
30. Lopez J, Fernandez-Hidalgo N, Revilla A, Vilacosta I, Tornos P, Almirante B, Sevilla T, Gomez I, Pozo E, Sarria C, San Roman JA. Internal and external validation of a model to predict adverse outcomes in patients with left-sided infective endocarditis. Heart 2011;97:1138-1142.
31. Thuny F, Giorgi R, Habachi R, Ansaldi S, LeDolley Y, Casalta JP, Avierinos JF, Riberi A, Renard S, Collart F, Raoult D, Habib G. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J 2012;164:94-101.
32. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miro JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 2011;306:2239-2247.
33. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, Cabell CH, Ramos AI, Fowler V Jr, Hoen B, Konecny P, Moreno A, Murdoch D, Pappas P, Sexton DJ, Spelman D, Tattevin P, Miro JM, van der Meer JT, Utili R. Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008;168:2095-2103.
34. Cabell CH, Abrutyn E, Fowler VG Jr, Hoen B, Miro JM, Corey GR, Olaison L, Pappas P, Anstrom KJ, Stafford JA, Eykyn S, Habib G, Mestres CA, Wang A. Use of surgery in patients with native valve infective endocarditis: results from the International Collaboration on Endocarditis Merged Database. Am Heart J 2005;150: 1092-1098.
35. Gelsomino S, Maessen JG, van der Veen F, Livi U, Renzulli A, Luca F, Carella R, Crudeli E, Rubino A, Rostagno C, Russo C, Borghetti V, Beghi C, De Bonis M, Gensini GF, Lorusso R. Emergency surgery for native mitral valve endocarditis: the impact of septic and cardiogenic shock. Ann Thor Surg 2012;93:1469-1476.
36. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Management of infective endocarditis: challenges and perspectives. Lancet 2012;379:965-975.
37. Tleyjeh IM, Steckelberg JM, Georgescu G, Ghomrawi HM, Hoskin TL, Enders FB, Mookadam F, Huskins WC, Wilson WR, Baddour LM. The association between the timing of valve surgeryand 6-month mortalityin left-sided infective endocarditis. Heart 2008;94:892-896.
38. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A, Giorgi R, Gouriet F, Tafanelli L, Avierinos JF, Renard S, Collart F, Raoult D, Habib G. The timing ofsurgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011;32:2027-2033.
39. De Feo M, Cotrufo M, Carozza A, De Santo LS, Amendolara F, Giordano S, Della Ratta EE, Nappi G, Della Corte A. The need for a specific risk prediction system in native valve infective endocarditis surgery. Sci World J 2012;2012:307571.